Clinical trial
Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or…
NCT00316511 · Agenus Inc., Industry · Completed
Key facts
| NCT number | NCT00316511 |
|---|---|
| Title | Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma |
| Official title | A Phase 1 Multi-Center, Dose Escalation and Pharmacokinetic Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma |
| Lead sponsor | Agenus Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malignancies, B-Cell Lymphoma |
| Intervention type | Drug |
| Interventions | Aroplatin |
| Enrollment | 21 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2008 |
| First posted | Apr 21, 2006 |
| Last update posted | Oct 27, 2008 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: